RELIZORB NEO
LIVE

Serial Number

99650604

Owner

Alcresta Therapeutics, Inc.

Attorney

Perry J. Viscounty

Filing Date

Feb 12, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RELIZORB NEO Trademark

Serial Number: 99650604

RELIZORB NEO is a trademark filed by Alcresta Therapeutics, Inc. on February 12, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Alcresta Therapeutics, Inc. (2 trademarks)

130 Turner Street, Building 3, Suite 200
Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

February 12, 2026

Registration Date

Not Registered

Published for Opposition

July 14, 2026

Goods & Services

Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders

Filters for medical purposes, namely, for processing and converting medical nutritional formula

Filing History

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 13, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 13, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 13, 2026 CNEA
ASSIGNED TO EXAMINER
Jun 13, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 12, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 12, 2026 MAFR
NEW APPLICATION ENTERED
Feb 12, 2026 NWAP